These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
824 related items for PubMed ID: 12091390
1. Silencing of transcription of the human luteinizing hormone receptor gene by histone deacetylase-mSin3A complex. Zhang Y, Dufau ML. J Biol Chem; 2002 Sep 06; 277(36):33431-8. PubMed ID: 12091390 [Abstract] [Full Text] [Related]
2. Trichostatin A, a histone deacetylase inhibitor, activates the IGFBP-3 promoter by upregulating Sp1 activity in hepatoma cells: alteration of the Sp1/Sp3/HDAC1 multiprotein complex. Choi HS, Lee JH, Park JG, Lee YI. Biochem Biophys Res Commun; 2002 Aug 30; 296(4):1005-12. PubMed ID: 12200149 [Abstract] [Full Text] [Related]
5. Protein kinase Calpha-induced derepression of the human luteinizing hormone receptor gene transcription through ERK-mediated release of HDAC1/Sin3A repressor complex from Sp1 sites. Liao M, Zhang Y, Dufau ML. Mol Endocrinol; 2008 Jun 30; 22(6):1449-63. PubMed ID: 18372343 [Abstract] [Full Text] [Related]
6. Histone deacetylase 1/mSin3A disrupts gamma interferon-induced CIITA function and major histocompatibility complex class II enhanceosome formation. Zika E, Greer SF, Zhu XS, Ting JP. Mol Cell Biol; 2003 May 30; 23(9):3091-102. PubMed ID: 12697811 [Abstract] [Full Text] [Related]
7. Phosphatidylinositol 3-kinase/protein kinase Czeta-induced phosphorylation of Sp1 and p107 repressor release have a critical role in histone deacetylase inhibitor-mediated derepression [corrected] of transcription of the luteinizing hormone receptor gene. Zhang Y, Liao M, Dufau ML. Mol Cell Biol; 2006 Sep 30; 26(18):6748-61. PubMed ID: 16943418 [Abstract] [Full Text] [Related]
8. Histone deacetylase inhibitors stimulate mitochondrial HMG-CoA synthase gene expression via a promoter proximal Sp1 site. Camarero N, Nadal A, Barrero MJ, Haro D, Marrero PF. Nucleic Acids Res; 2003 Mar 15; 31(6):1693-703. PubMed ID: 12626711 [Abstract] [Full Text] [Related]
10. Histone deacetylase inhibitors activate INK4d gene through Sp1 site in its promoter. Yokota T, Matsuzaki Y, Miyazawa K, Zindy F, Roussel MF, Sakai T. Oncogene; 2004 Jul 08; 23(31):5340-9. PubMed ID: 15107822 [Abstract] [Full Text] [Related]
11. Repression of the luteinizing hormone receptor gene promoter by cross talk among EAR3/COUP-TFI, Sp1/Sp3, and TFIIB. Zhang Y, Dufau ML. Mol Cell Biol; 2003 Oct 08; 23(19):6958-72. PubMed ID: 12972613 [Abstract] [Full Text] [Related]
13. The histone deacetylase inhibitor trichostatin A mediates upregulation of 5-lipoxygenase promoter activity by recruitment of Sp1 to distinct GC-boxes. Schnur N, Seuter S, Katryniok C, Rådmark O, Steinhilber D. Biochim Biophys Acta; 2007 Oct 08; 1771(10):1271-82. PubMed ID: 17894944 [Abstract] [Full Text] [Related]
16. Trichostatin A induces transforming growth factor beta type II receptor promoter activity and acetylation of Sp1 by recruitment of PCAF/p300 to a Sp1.NF-Y complex. Huang W, Zhao S, Ammanamanchi S, Brattain M, Venkatasubbarao K, Freeman JW. J Biol Chem; 2005 Mar 18; 280(11):10047-54. PubMed ID: 15647279 [Abstract] [Full Text] [Related]
17. Requirement of a specific Sp1 site for histone deacetylase-mediated repression of transforming growth factor beta Type II receptor expression in human pancreatic cancer cells. Zhao S, Venkatasubbarao K, Li S, Freeman JW. Cancer Res; 2003 May 15; 63(10):2624-30. PubMed ID: 12750289 [Abstract] [Full Text] [Related]